
<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>EMMEPLUS</title>
	<atom:link href="http://www.emmeplus.eu/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.emmeplus.eu</link>
	<description>Strategic Advisory</description>
	<lastBuildDate>Fri, 18 May 2012 16:13:17 +0000</lastBuildDate>
	<language>it</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.2</generator>
<xhtml:meta xmlns:xhtml="http://www.w3.org/1999/xhtml" name="robots" content="noindex" />
		<item>
		<title>Life Science Bio Alert &#8211; May 2012</title>
		<link>http://www.emmeplus.eu/2012/05/life-science-bio-alert-may-2012/</link>
		<comments>http://www.emmeplus.eu/2012/05/life-science-bio-alert-may-2012/#comments</comments>
		<pubDate>Fri, 18 May 2012 16:06:26 +0000</pubDate>
		<dc:creator>a.messina</dc:creator>
				<category><![CDATA[Homepage News]]></category>
		<category><![CDATA[News]]></category>
		<category><![CDATA[Newsletter]]></category>

		<guid isPermaLink="false">http://www.emmeplus.eu/?p=4750</guid>
		<description><![CDATA[On a continuing basis Emmeplus Life Science team monitors all biotechnology, clinical trial, pharmaceutical and other related life science regulatory matters across the World and particularly USA, Israel, India, United Arab Emirates, European Union and the 27 Member States. This issue presents the following stories: USA  Center For Drug Evaluation and Research &#8211; Guidance Documents The Challenges [...]]]></description>
			<content:encoded><![CDATA[<p>On a continuing basis<strong> Emmeplus Life Science</strong> <strong>team </strong>monitors all biotechnology, clinical trial, pharmaceutical and other related life science regulatory matters across the World and particularly <strong>USA</strong>, <strong>Israel</strong>, <strong>India,</strong> <strong>United Arab Emirates, European Union</strong> and the <strong>27 Member States.</strong></p>
<p>This issue presents the following stories:</p>
<p><strong>USA</strong></p>
<ul>
<li><strong> </strong>Center For Drug Evaluation and Research &#8211; Guidance Documents</li>
<li>The Challenges of Implementing Innovations in Drug Development</li>
</ul>
<p><strong>ISRAEL</strong></p>
<ul>
<li>64</li>
<li>Israeli drug could save stroke victims</li>
</ul>
<p><strong>INDIA</strong></p>
<ul>
<li> Biotechnology Industry Research Assistance Council (BIRAC)</li>
<li>Department of Health research &#8211; Annual report 2011-2012</li>
</ul>
<p><strong> </strong><strong>UNITED ARAB EMIRATES</strong></p>
<ul>
<li> Dubai Biotechnology and Research Park (DuBiotech) Announces Opening of First Industrial Biotech Laboratory</li>
</ul>
<p><strong> </strong><strong>EUROPE</strong></p>
<ul>
<li>Reflection paper on classification of advanced therapies released for public consultation</li>
</ul>
<ul>
<li><strong>Bulgaria:</strong> To the attention of holders of marketing authorizations<strong></strong></li>
<li><strong>Denmark:</strong> Drug Analysis Prints with data from more than 14,000 side effect reports</li>
<li><strong>Estonia:</strong> Registry of activity licenses in English<strong></strong></li>
<li><strong>Finland:</strong> New national Medicines Information Strategy for Finland<strong></strong></li>
<li><strong></strong><strong>France: </strong>Active implantable medical device (DMIA) usable in cardiology</li>
<li><strong>Germany: </strong>Online Variation Submission using the internet portal PharmNet.Bund</li>
<li><strong>Italy: </strong>A new regulation within the AIFA has been approved<strong></strong></li>
<li><strong>Lithuania: </strong>Regarding medicinal products for which the „sunset clause“ may already be applied<strong></strong></li>
<li><strong>Slovak Republic: </strong>Additional <a href="http://www.sukl.sk/en/registration-of-medicinal-product/forms-and-instructions/additional-requirements-for-submission-of-the-dossier-in-the-slovak-republic?page_id=1945">requirements</a> for submission of the dossier in the Slovak Republic<strong></strong></li>
<li><strong>Sweden: </strong>5,7 million Euro to Swedish research on environmental impact of pharmaceuticals<strong></strong></li>
<li><strong>United Kingdom: </strong>The new pharmacovigilance legislation: Information for Marketing Authorisation Holders</li>
</ul>
<p>Read the full <a href="http://www.emmeplus.eu/wp-content/uploads/2012/05/LS-alert.pdf">LS alert</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.emmeplus.eu/2012/05/life-science-bio-alert-may-2012/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Strategic Advisory Newsletter &#8211; maggio 2012</title>
		<link>http://www.emmeplus.eu/2012/05/strategic-advisory-newsletter-maggio-2012/</link>
		<comments>http://www.emmeplus.eu/2012/05/strategic-advisory-newsletter-maggio-2012/#comments</comments>
		<pubDate>Mon, 14 May 2012 16:00:04 +0000</pubDate>
		<dc:creator>a.messina</dc:creator>
				<category><![CDATA[Homepage News]]></category>
		<category><![CDATA[News]]></category>

		<guid isPermaLink="false">http://www.emmeplus.eu/?p=4727</guid>
		<description><![CDATA[Emmeplus è lieta di presentare la newsletter informativa dedicata ad approfondimenti e novità in materia giuridica, finanziaria e sviluppo tecnologico. Questo mese ci siamo occupati di: Mercato Francese Facilitazione per le imprese in Francia Bando INNOVAZIONE per aziende del settore dei servizi, del commercio e del turismo Contributi a imprese industriali per formazione professionale Nella sezione [...]]]></description>
			<content:encoded><![CDATA[<p>Emmeplus è lieta di presentare <strong></strong>la newsletter informativa dedicata ad <strong>approfondimenti e novità in materia giuridica, finanziaria e sviluppo tecnologico</strong>.</p>
<p>Questo mese ci siamo occupati di:</p>
<ul>
<li><strong>Mercato Francese</strong></li>
<li><strong>Facilitazione per le imprese in Francia</strong></li>
<li><strong>Bando INNOVAZIONE</strong> per aziende del settore dei servizi, del commercio e del turismo</li>
<li><strong>Contributi a imprese industriali per formazione professionale</strong></li>
</ul>
<p>Nella sezione <strong>News Mercati</strong>, dedicata alle notizie più significative provenienti dai Paesi in cui operiamo, Vi segnaliamo:</p>
<ul>
<li><strong>Aumento del tasso di crescita in India</strong></li>
<li><strong>Disoccupazione negli USA</strong></li>
<li><strong>Trend dell&#8217;economia israeliana</strong></li>
</ul>
<p><a href="http://www.emmeplus.eu/wp-content/uploads/2012/05/Newsletter-maggio.pdf">Newsletter maggio</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.emmeplus.eu/2012/05/strategic-advisory-newsletter-maggio-2012/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Fabio Marazzi confermato nel cda di Expo 2015</title>
		<link>http://www.emmeplus.eu/2012/05/fabio-marazzi-confermato-nel-cda-di-expo-2015/</link>
		<comments>http://www.emmeplus.eu/2012/05/fabio-marazzi-confermato-nel-cda-di-expo-2015/#comments</comments>
		<pubDate>Thu, 10 May 2012 06:07:33 +0000</pubDate>
		<dc:creator>a.messina</dc:creator>
				<category><![CDATA[Comunicati Stampa]]></category>
		<category><![CDATA[Homepage News]]></category>
		<category><![CDATA[News]]></category>

		<guid isPermaLink="false">http://www.emmeplus.eu/?p=4724</guid>
		<description><![CDATA[Abbiamo piacere di informare che il Presidente di Regione Lombardia, Roberto Formigoni, ha confermato Fabio Marazzi quale componente del consiglio di amministrazione di Expo 2015 S.p.A per il prossimo triennio.]]></description>
			<content:encoded><![CDATA[<p>Abbiamo piacere di informare che il Presidente di Regione Lombardia, Roberto Formigoni, ha confermato <strong>Fabio Marazzi</strong> quale componente del <strong>consiglio di amministrazione di Expo 2015 S.p.A</strong> per il prossimo triennio.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.emmeplus.eu/2012/05/fabio-marazzi-confermato-nel-cda-di-expo-2015/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>2012 ECTA European Cutting Tool Conference</title>
		<link>http://www.emmeplus.eu/2012/05/2012-ecta-european-cutting-tool-conference/</link>
		<comments>http://www.emmeplus.eu/2012/05/2012-ecta-european-cutting-tool-conference/#comments</comments>
		<pubDate>Mon, 07 May 2012 11:21:03 +0000</pubDate>
		<dc:creator>a.messina</dc:creator>
				<category><![CDATA[Homepage News]]></category>
		<category><![CDATA[News]]></category>

		<guid isPermaLink="false">http://www.emmeplus.eu/?p=4710</guid>
		<description><![CDATA[May, 17-18. Hotel Cenobio dei Dogi, Camogli (Genoa), Italy 2012 ECTA European Cutting Tool Conference is the event conference set by the European Manufacturers of Cutting Tools, the central organization for furthering the interests of all European cutting tool manufacturing companies and entities. On May the 18th (day 2), Fabio Marazzi has been invited to [...]]]></description>
			<content:encoded><![CDATA[<p><em>May, 17-18. Hotel Cenobio dei Dogi, Camogli (Genoa), Italy</em></p>
<p>2012 ECTA European Cutting Tool Conference is the event conference set by the European Manufacturers of Cutting Tools, the central organization for furthering the interests of all European cutting tool manufacturing companies and entities.</p>
<p>On <strong>May the 18th </strong>(day 2),<strong> Fabio Marazzi</strong> has been invited to join the event and will give a lecture titled <em><strong>I</strong><strong><em>n</em>dia and China, Opportunities, Protection and Market trends.</strong></em></p>
<p>The conference sees the participation of key figures and speakers form all over the world and experts in the field, both from the economic, the financial and the international stanpoints. The high ranking program reflects the objectives of the metal-cutting business and provide excellent opportunities for interacting with industry colleagues.</p>
<p>The Conference, with numerous attendees from Europe, and guests from America and Asia is this year`s top event of the cutting tool industry.</p>
<p><a href="http://www.emmeplus.eu/wp-content/uploads/2012/05/elettronico_ProgrECTA_low.pdf">ProgrECTA</a></p>
<p><a href="http://www.emmeplus.eu/wp-content/uploads/2012/05/biographies+and+abstracts+all.pdf">biographies+and+abstracts+all</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.emmeplus.eu/2012/05/2012-ecta-european-cutting-tool-conference/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Soraya Abushaaban</title>
		<link>http://www.emmeplus.eu/2012/05/soraya-abushaaban/</link>
		<comments>http://www.emmeplus.eu/2012/05/soraya-abushaaban/#comments</comments>
		<pubDate>Mon, 07 May 2012 10:10:23 +0000</pubDate>
		<dc:creator>a.messina</dc:creator>
				<category><![CDATA[Staff]]></category>

		<guid isPermaLink="false">http://www.emmeplus.eu/?p=4702</guid>
		<description><![CDATA[Strategic Advisory Team s.abushaaban@emmeplus.eu Born in 1987. She graduated in International Business Economics at the University of Bergamo (2009) and she took a MA degree in Economics and Management of Public Administration and International Institutions at Bocconi University in Milan.]]></description>
			<content:encoded><![CDATA[<p>Strategic Advisory Team<br />
<a href="s.abushaaban@emmeplus.eu">s.abushaaban@emmeplus.eu</a></p>
<p>Born in 1987. She graduated in International Business Economics at the University of Bergamo (2009) and she took a MA degree in Economics and Management of Public Administration and International Institutions at Bocconi University in Milan.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.emmeplus.eu/2012/05/soraya-abushaaban/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>ISRAEL Aerospace Industry</title>
		<link>http://www.emmeplus.eu/2012/05/israel-aerospace-industry/</link>
		<comments>http://www.emmeplus.eu/2012/05/israel-aerospace-industry/#comments</comments>
		<pubDate>Mon, 07 May 2012 09:29:28 +0000</pubDate>
		<dc:creator>a.messina</dc:creator>
				<category><![CDATA[News]]></category>

		<guid isPermaLink="false">http://www.emmeplus.eu/?p=4698</guid>
		<description><![CDATA[Ci spiace, ma questo articolo è disponibile soltanto in English.]]></description>
			<content:encoded><![CDATA[<p>Ci spiace, ma questo articolo è disponibile soltanto in <a href="http://www.emmeplus.eu/feed/?lang=en">English</a>.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.emmeplus.eu/2012/05/israel-aerospace-industry/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>ISRAEL HomeLand Security Industry</title>
		<link>http://www.emmeplus.eu/2012/05/israel-homeland-security-industry/</link>
		<comments>http://www.emmeplus.eu/2012/05/israel-homeland-security-industry/#comments</comments>
		<pubDate>Mon, 07 May 2012 09:17:15 +0000</pubDate>
		<dc:creator>a.messina</dc:creator>
				<category><![CDATA[News]]></category>

		<guid isPermaLink="false">http://www.emmeplus.eu/?p=4695</guid>
		<description><![CDATA[Homeland Security – Protecting Our Way of Life Responding to the domestic, cross-border, and international terror threats that have emerged in the years since 9/11, the majority of the world’s nations are now combating security risks by increasing their investment in homeland security. The protection of transportation, infrastructure, and strategic assets has, in particular, become [...]]]></description>
			<content:encoded><![CDATA[<p><strong>Homeland Security – Protecting Our Way of Life</strong></p>
<p>Responding to the domestic, cross-border, and international terror threats that have emerged in the years since 9/11, the majority of the world’s nations are now combating security risks by increasing their investment in homeland security. The protection of transportation, infrastructure, and strategic assets has, in particular, become a priority.</p>
<p>Israeli technology, developed to safeguard Israel’s national security, is both sophisticated and innovative, and among the best in the world in this regard.</p>
<p>Aviation security, one of the most visible aspects of homeland security operations, is attracting significant investments in infrastructure, operations, and support. Such systems support the extensive efforts that are currently being invested in securing modern cities, by integrating existing surveillance capabilities with highly sophisticated situational<br />
awareness, and the command and control centers that empower &#8220;safe city&#8221; initiatives.</p>
<p>These systems also work in collaboration with law enforcement, traffic management, and general security procedures in urban domains. In addition, cutting-edge information technology supports national biometric identification systems such as e-passports, which are currently being issued by several European and Asian countries.</p>
<p>The analysis has been conducted by the <strong>Israel Export &amp; International Cooperation Institute</strong></p>
<p><a href="http://www.emmeplus.eu/wp-content/uploads/2012/05/HLS-Brief.pdf">HLS Brief</a></p>
<p>&nbsp;</p>
]]></content:encoded>
			<wfw:commentRss>http://www.emmeplus.eu/2012/05/israel-homeland-security-industry/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Tips for doing business in Israel</title>
		<link>http://www.emmeplus.eu/2012/05/tips-for-doing-business-in-israel/</link>
		<comments>http://www.emmeplus.eu/2012/05/tips-for-doing-business-in-israel/#comments</comments>
		<pubDate>Mon, 07 May 2012 09:12:31 +0000</pubDate>
		<dc:creator>a.messina</dc:creator>
				<category><![CDATA[Documenti]]></category>
		<category><![CDATA[News]]></category>

		<guid isPermaLink="false">http://www.emmeplus.eu/?p=4691</guid>
		<description><![CDATA[Ci spiace, ma questo articolo è disponibile soltanto in English.]]></description>
			<content:encoded><![CDATA[<p>Ci spiace, ma questo articolo è disponibile soltanto in <a href="http://www.emmeplus.eu/feed/?lang=en">English</a>.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.emmeplus.eu/2012/05/tips-for-doing-business-in-israel/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>ISRAEL – MEDICAL DEVICES MARKET</title>
		<link>http://www.emmeplus.eu/2012/05/english-israel-medical-devices-market/</link>
		<comments>http://www.emmeplus.eu/2012/05/english-israel-medical-devices-market/#comments</comments>
		<pubDate>Mon, 07 May 2012 08:16:43 +0000</pubDate>
		<dc:creator>a.messina</dc:creator>
				<category><![CDATA[Documenti]]></category>
		<category><![CDATA[News]]></category>

		<guid isPermaLink="false">http://www.emmeplus.eu/?p=4683</guid>
		<description><![CDATA[Ci spiace, ma questo articolo è disponibile soltanto in English.]]></description>
			<content:encoded><![CDATA[<p>Ci spiace, ma questo articolo è disponibile soltanto in <a href="http://www.emmeplus.eu/feed/?lang=en">English</a>.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.emmeplus.eu/2012/05/english-israel-medical-devices-market/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Fabio Marazzi è entrato nel cda della holding Angelantoni Industrie S.p.A</title>
		<link>http://www.emmeplus.eu/2012/04/fabio-marazzi-e-entrato-nel-cda-della-holding-angelantoni-industrie-s-p-a/</link>
		<comments>http://www.emmeplus.eu/2012/04/fabio-marazzi-e-entrato-nel-cda-della-holding-angelantoni-industrie-s-p-a/#comments</comments>
		<pubDate>Fri, 27 Apr 2012 15:10:26 +0000</pubDate>
		<dc:creator>a.messina</dc:creator>
				<category><![CDATA[Comunicati Stampa]]></category>
		<category><![CDATA[Homepage News]]></category>
		<category><![CDATA[News]]></category>

		<guid isPermaLink="false">http://www.emmeplus.eu/?p=4638</guid>
		<description><![CDATA[Fabio Marazzi è entrato a far parte del consiglio di amministrazione della holding Angelantoni Industrie S.p.A. Il gruppo Angelantoni è leader nel settore delle camere prove ambientali simulate e dei simulatori spaziali; nell’ambito delle apparecchiature frigorifere per il mantenimento e lo stoccaggio delle materia biologiche e, attraverso la controllata Archimede Solar Energy spa, nel settore [...]]]></description>
			<content:encoded><![CDATA[<p>Fabio Marazzi è entrato a far parte del consiglio di amministrazione della holding Angelantoni Industrie S.p.A.</p>
<p>Il gruppo Angelantoni è leader nel settore delle camere prove ambientali simulate e dei simulatori spaziali; nell’ambito delle apparecchiature frigorifere per il mantenimento e lo stoccaggio delle materia biologiche e, attraverso la controllata Archimede Solar Energy spa, nel settore della produzione di tubi ricevitori per centrali solari termodinamiche.</p>
<p><a href="http://www.angelantoni.it/">Link</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.emmeplus.eu/2012/04/fabio-marazzi-e-entrato-nel-cda-della-holding-angelantoni-industrie-s-p-a/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

